Wilbert Zwart completed his PhD at the Netherlands Cancer institute (NKI; Amsterdam) in 2009, and received his post-doctoral training at the CRUK-CI in Cambridge (UK), in the lab of prof. Jason Carroll. In 2011, Wilbert returned to the Netherlands to open his independent research lab at the NKI studying hormone-dependent cancers, focusing on hormone receptor biology, epigenetics and gene regulation. His projects have a ‘full circle’ design, connecting basic scientific discoveries, translational research and clinical trials. By implementing functional genomics and molecular endocrinology in innovative clinical trials, basic scientific breakthroughs can be best-connected with the patient, allowing for a swift translation of his discoveries to the clinic. In 2018, he was appointed senior groupleader at the NKI, as well as full professor at the Eindhoven University of Technology, and is member of Oncode Institute. He serves as Chair of the NKI Translational Research Board, theme lead Precision Oncology of the NKI and takes seat in the Board of Directors of Cancer Core Europe.